Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Cancer Care & Hematolog Specialists of Chicagoland- US Oncology
mi
from
Niles, IL
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Cancer Care & Hematolog Specialists of Chicagoland- US Oncology
mi
from
Niles, IL
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Central Indiana Cancer Centers- US Oncology
mi
from
Indianapolis, IN
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Central Indiana Cancer Centers- US Oncology
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Hope Center- US Oncology
mi
from
Terre Haute, IN
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Hope Center- US Oncology
mi
from
Terre Haute, IN
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
University of Kentucky, Hematology/Oncology/BMT Clinical Research
mi
from
Lexington, KY
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
University of Kentucky, Hematology/Oncology/BMT Clinical Research
mi
from
Lexington, KY
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Lahey Clinic
mi
from
Burlington, MA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Kansas City Cancer Center, LLC- US Oncology
mi
from
Kansas City, MO
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Kansas City Cancer Center, LLC- US Oncology
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Comprehensive Cancer Centers of Nevada- US Oncology
mi
from
Las Vegas, NV
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada- US Oncology
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Hunterdon Regional Cancer Center
mi
from
Flemington, NJ
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Hunterdon Regional Cancer Center
mi
from
Flemington, NJ
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Hematology Oncology Associates
mi
from
Mount Holly, NJ
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Hematology Oncology Associates
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Hematology Oncology Associates, PC
mi
from
Albuquerque, NM
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Hematology Oncology Associates, PC
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
University of New Mexico Cancer Center - South
mi
from
Las Cruces, NM
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
University of New Mexico Cancer Center - South
mi
from
Las Cruces, NM
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
New Mexico Cancer Care Associates- US Oncology
mi
from
Santa Fe, NM
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
New Mexico Cancer Care Associates- US Oncology
mi
from
Santa Fe, NM
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of North Carolina- US Oncology
mi
from
Raleigh, NC
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of North Carolina- US Oncology
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Medical Onc Assoc of Wyoming Valley, PC- US Oncology
mi
from
Kingston, PA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Medical Onc Assoc of Wyoming Valley, PC- US Oncology
mi
from
Kingston, PA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Pottstown Memorial Medical Center
mi
from
Pottstown, PA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Pottstown Memorial Medical Center
mi
from
Pottstown, PA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Associates in Hematology-Oncology P.C. US Oncology
mi
from
Upland, PA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Associates in Hematology-Oncology P.C. US Oncology
mi
from
Upland, PA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Reading Hospital Regional Medical Center
mi
from
West Reading, PA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Reading Hospital Regional Medical Center
mi
from
West Reading, PA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Sanford Clinic
mi
from
Sioux Falls, SD
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Sanford Clinic
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Amarillo- US Oncology
mi
from
Amarillo, TX
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Amarillo- US Oncology
mi
from
Amarillo, TX
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Mamie Mcfaddin Ward Cancer Center, Texas Oncology- US Oncology
mi
from
Beaumont, TX
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Mamie Mcfaddin Ward Cancer Center, Texas Oncology- US Oncology
mi
from
Beaumont, TX
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Texas Oncology P.A.- Bedford- US Oncology
mi
from
Bedford, TX
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Texas Oncology P.A.- Bedford- US Oncology
mi
from
Bedford, TX
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Texas Cancer Center at Medical City- US Oncology
mi
from
Dallas, TX
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Texas Cancer Center at Medical City- US Oncology
mi
from
Dallas, TX
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Texas Oncology P.A. - Dallas- US Oncology
mi
from
Dallas, TX
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Texas Oncology P.A. - Dallas- US Oncology
mi
from
Dallas, TX
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Methodist Charlton Cancer Center - Texas Oncology- US Oncology
mi
from
Dallas, TX
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Methodist Charlton Cancer Center - Texas Oncology- US Oncology
mi
from
Dallas, TX
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Odessa- US Oncology
mi
from
Odessa, TX
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Odessa- US Oncology
mi
from
Odessa, TX
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Scott and White Hospital and Clinics
mi
from
Temple, TX
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Scott and White Hospital and Clinics
mi
from
Temple, TX
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Texas Oncology Cancer Care and Research Center- US Oncology
mi
from
Waco, TX
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Texas Oncology Cancer Care and Research Center- US Oncology
mi
from
Waco, TX
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Texoma Cancer Center- US Oncology
mi
from
Wichita Falls, TX
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Texoma Cancer Center- US Oncology
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Virginia Oncology Associates- US Oncology
mi
from
Norfolk, VA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Virginia Oncology Associates- US Oncology
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Onc & Hematology Assoc. of Southern VA, Inc D.B.A. - US Oncology
mi
from
Salem, VA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Onc & Hematology Assoc. of Southern VA, Inc D.B.A. - US Oncology
mi
from
Salem, VA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Swedish Cancer Institute
mi
from
Seattle, WA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Cancer Care Northwest, US Oncology
mi
from
Spokane, WA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Cancer Care Northwest, US Oncology
mi
from
Spokane, WA
Click here to add this to my saved trials
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated:  12/31/1969
Northwest Cancer Specialists- US Oncology
mi
from
Vancouver, WA
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)
Status: Enrolling
Updated: 12/31/1969
Northwest Cancer Specialists- US Oncology
mi
from
Vancouver, WA
Click here to add this to my saved trials
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer
A Phase I Study of Immune Checkpoint Inhibition (Anti-CTLA4 and/or Anti-PD-L1) in Combination With Radiation Therapy in Patients With Unresectable and Non-metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/31/1969
Georgetown University Medical Center
mi
from
Washington,
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer
A Phase I Study of Immune Checkpoint Inhibition (Anti-CTLA4 and/or Anti-PD-L1) in Combination With Radiation Therapy in Patients With Unresectable and Non-metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/31/1969
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer
A Phase I Study of Immune Checkpoint Inhibition (Anti-CTLA4 and/or Anti-PD-L1) in Combination With Radiation Therapy in Patients With Unresectable and Non-metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
mi
from
New York, NY
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer
A Phase I Study of Immune Checkpoint Inhibition (Anti-CTLA4 and/or Anti-PD-L1) in Combination With Radiation Therapy in Patients With Unresectable and Non-metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer
A Phase I Study of Immune Checkpoint Inhibition (Anti-CTLA4 and/or Anti-PD-L1) in Combination With Radiation Therapy in Patients With Unresectable and Non-metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer
A Phase I Study of Immune Checkpoint Inhibition (Anti-CTLA4 and/or Anti-PD-L1) in Combination With Radiation Therapy in Patients With Unresectable and Non-metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer
Phase II Trial of Adjuvant Thalidomide Following Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis or Adenomucinosis From Colorectal/Appendiceal Cancer
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer
Phase II Trial of Adjuvant Thalidomide Following Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis or Adenomucinosis From Colorectal/Appendiceal Cancer
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Santa Rosa Memorial Hospital
mi
from
Santa Rosa, CA
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Santa Rosa Memorial Hospital
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Redwood Regional Medical Group, Inc.
mi
from
Santa Rosa, CA
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Redwood Regional Medical Group, Inc.
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Click here to add this to my saved trials
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated:  12/31/1969
MBCCOP - Howard University Cancer Center
mi
from
Washington,
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated: 12/31/1969
MBCCOP - Howard University Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated:  12/31/1969
University of Miami Sylvester Comprehensive Cancer Center - Miami
mi
from
Miami, FL
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients
Status: Enrolling
Updated: 12/31/1969
University of Miami Sylvester Comprehensive Cancer Center - Miami
mi
from
Miami, FL
Click here to add this to my saved trials